METAGENICS VIRACLEAR

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

Astragalus membranaceus, Quantity: 200 mg (Equivalent: Astragalus membranaceus, Qty 2 g); lysine hydrochloride, Quantity: 800 mg; zinc sulfate monohydrate, Quantity: 32.97 mg (Equivalent: zinc, Qty 12 mg); ascorbic acid, Quantity: 250 mg

Disponible depuis:

Metagenics (Aust) Pty Ltd

DCI (Dénomination commune internationale):

Ascorbic acid,Astragalus membranaceus,Lysine hydrochloride,Zinc sulfate monohydrate

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: silicon dioxide; hyprolose; hypromellose; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; stearic acid

Mode d'administration:

Oral

indications thérapeutiques:

Enhance/improve/promote immune defence/immunity ; Maintain/support healthy immune system function ; Traditionally used in Chinese medicine to Maintain/support healthy immune system function ; Traditionally used in Chinese medicine to Adaptogen/Help body adapt to stress ; Helps reduce occurrence of facial cold sores ; Decrease/reduce/relieve burning/tingling associated with facial cold sores ; Decrease/reduce/relieve symptoms of facial cold sores ; Decrease/reduce/relieve symptoms of facial cold sores (Linked Indication:Analgesic/Anodyne/relieve pain; Maintain/support skin repair/healing/regeneration)

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2010-09-25